Balance Sheet Data
Cara Therapeutics, Inc. (CARA)
$1.25
+0.05 (+4.17%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 161.38 | 155.01 | 180.92 | 167.04 | 145.40 | 683.76 | 1,753.46 | 4,496.67 | 11,531.50 | 29,571.99 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 1.59 | 1.79 | 2.06 | 1.15 | 4.45 | 8.15 | 20.90 | 53.60 | 137.46 | 352.51 |
| Account Receivables (%) | ||||||||||
| Inventories | - | -0.82 | -1.51 | 2.58 | 2.38 | 3.14 | 8.05 | 20.64 | 52.94 | 135.75 |
| Inventories (%) | ||||||||||
| Accounts Payable | 4.37 | 9.10 | 4.89 | 5.63 | 9.60 | 27.74 | 71.15 | 182.45 | 467.89 | 1,199.89 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.07 | -0.02 | -0.35 | -0.04 | -0.04 | -0.25 | -0.64 | -1.64 | -4.21 | -10.80 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.